Oct 17, 2023 · What is talazoparib? Talazoparib is used in adults to treat certain type of breast cancer that has spread to other parts of the body. Talazoparib is also used in adults in combination with other drugs to treat prostate cancer that has spread to other parts of the body and when surgery or other treatments to decrease testosterone levels have not ...

Talazoparib, sold under the brand name Talzenna, is an anti-cancer medication used for the treatment of breast cancer and prostate cancer. [6] It is an orally available poly ADP ribose polymerase PARP inhibitor marketed by Pfizer for the treatment of advanced breast cancer with germline BRCA mutations . [ 9 ]

TALZENNA ® treats g BRCA -mutated, HER2- breast cancer that is locally advanced or metastatic. TALZENNA is a proven alternative to chemotherapy in a convenient once-daily oral dose. LEARN ABOUT TALZENNA. gBRCA=germline (or inherited) BRCA, HER2-=human epidermal growth factor receptor 2 (HER2)-negative. TALZENNA is a prescription medicine used:

Oct 21, 2024 · Talzenna (talazoparib) is commonly used to treat certain breast and prostate cancers. Talzenna may also be used for other conditions as determined by your healthcare provider.

Talazoparib is used to treat HER2-negative locally advanced or metastatic breast cancer (cancer that has spread) with a deleterious or suspected deleterious BRCA mutation gene. Your doctor will use a test to check for this mutation before you receive the medicine.

Talazoparib (Talzenna) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.

1 day ago · Talazoparib is a poly (adenosine diphosphate-ribose) polymerase inhibitor. TALAPRO-2 enrolled two groups of patients with previously untreated metastatic castration-resistant prostate cancer.

Talazoparib is used alone to treat certain types of breast cancer that has spread within the breast or to other areas of the body. Talazoparib is also used with enzalutamide (Xtandi) to treat certain types of prostate cancer that has spread to other parts of the body in men and who have not been helped by certain medical and surgical treatments ...

Talazoparib is a type of targeted cancer drug. You pronounce it as tal-ah-zo-pa-rib. It is also known as Talzenna. This treatment is for people with HER2 negative breast cancer who have an abnormal change (mutation) in the BRCA1 or BRCA2 genes. You might have talazoparib if you have: secondary breast cancer .

1 day ago · Talazoparib was discontinued in 13.1% of patients due to AEs, with 4.5% discontinuing the drug due to anemia. Mike Bassett is a staff writer focusing on oncology and hematology. He is based in ...